Journal of health economics and outcomes research

HIGHLIGHTS

• who: Atallah EL et al. from the of patients with CML-CP reaching later lines of therapy or progressing to AP/BC in the United States have published the article: Journal of Health Economics and Outcomes Research, in the Journal: (JOURNAL) of March/02,/2022
• future: Although there is little information on HSCT-associated costs in later lines of therapy for patients with CML-CP results from this study are consistent with a previous study that reported annual HCST costs in claims 1 year post-TKI treatment failure which ranged between $210 612 and $243 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.